Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion type Assertion NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_head.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion description "[This study explored the use of interleukin 2 (IL-2) and interferon gamma (IFN-gamma) gene-modified tumor cells as cellular vaccines for the treatment of bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_provenance.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion evidence source_evidence_literature NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_provenance.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion SIO_000772 8459207 NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_provenance.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion wasDerivedFrom befree-20150227 NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_provenance.
- NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_assertion wasGeneratedBy ECO_0000203 NP480529.RA6ADgh2MiGSvp9juL9ly7Q5lJ3k7XHjM56C_ZkNRRhYM130_provenance.